3NC
MTEM

300 North Capital’s Molecular Templates, Inc. MTEM Stock Holding History

300 North Capital’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-62
Closed -$54K – 126
2013
Q2 		$54K Buy
+62
New +$52.4K 0.02% 111

Other funds holding MTEM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

300 North Capital's MTEM Position: Q3 2013 in Review

300 North Capital sold out of Molecular Templates, Inc. (MTEM) in Q3 2013, closing a stake of 62 shares — an estimated $54K sold.

300 North Capital first reported a position in MTEM in Q2 2013 and held it in 1 quarter. The position peaked at $54K in Q2 2013. 86 funds tracked by Wall St. Rank hold MTEM as of Q3 2013.

  • 300 North Capital reported no remaining Molecular Templates, Inc. position as of Q3 2013 after selling out during the quarter.
  • 300 North Capital sold 62 Molecular Templates, Inc. shares in Q3 2013, an estimated $54K.
  • 300 North Capital first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 1 quarter.
  • 300 North Capital's Molecular Templates, Inc. position peaked at $54K in Q2 2013.
  • 86 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2013.

Based on 300 North Capital's 13F filing for Q3 2013, filed 12 Nov 2013.